Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rusckowski

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Cancer|December 24, 1997
Early results in the irrational design of new bifunctional chelatorsF Chang, M Rusckowski, T Qu, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|December 24, 1997
Technetium-99m labeled epidermal growth factor-tumor imaging in miceM Rusckowski, T Qu, F Chang, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 2, 1999
NHS-MAS3: a bifunctional chelator alternative to NHS-MAG3F Chang, T Qu, M Rusckowski, et al.
Journal of Interferon Research|January 1, 1982
Chemical modification of mouse interferonsM Rusckowski, M Paucker, B Dalton, et al.
Cancer|December 24, 1997
Pretargeting using peptide nucleic acidM Rusckowski, T Qu, F Chang, et al.
Nuclear Medicine Communications|January 1, 1996
Protein labelling via deoxyribonucleic acid hybridizationD J Hnatowich, G Mardirossian, M Rusckowski, et al.
Nuclear Medicine and Biology|April 1, 1997
Effect of endogenous biotin on the applications of streptavidin and biotin in miceM Rusckowski, M Fogarasi, B Fritz, et al.
Journal of Immunological Methods|February 11, 1985
A simple in vitro method of screening panels of monoclonal antibodies for tumor bindingM Rusckowski, P W Doherty, F Virzi, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|June 1, 1996
Investigations of directly labeling antibodies with rhenium-188P Winnard, E Virzi, M Fogarasi, et al.
Nuclear Medicine and Biology|February 1, 1993
Improved tumor localization with (strept)avidin and labeled biotin as a substitute for antibodyD J Hnatowich, B Fritz, F Virzi, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Cancer|December 24, 1997
Early results in the irrational design of new bifunctional chelatorsF Chang, M Rusckowski, T Qu, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|December 24, 1997
Technetium-99m labeled epidermal growth factor-tumor imaging in miceM Rusckowski, T Qu, F Chang, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 2, 1999
NHS-MAS3: a bifunctional chelator alternative to NHS-MAG3F Chang, T Qu, M Rusckowski, et al.
Journal of Interferon Research|January 1, 1982
Chemical modification of mouse interferonsM Rusckowski, M Paucker, B Dalton, et al.
Cancer|December 24, 1997
Pretargeting using peptide nucleic acidM Rusckowski, T Qu, F Chang, et al.
Nuclear Medicine Communications|January 1, 1996
Protein labelling via deoxyribonucleic acid hybridizationD J Hnatowich, G Mardirossian, M Rusckowski, et al.
Nuclear Medicine and Biology|April 1, 1997
Effect of endogenous biotin on the applications of streptavidin and biotin in miceM Rusckowski, M Fogarasi, B Fritz, et al.
Journal of Immunological Methods|February 11, 1985
A simple in vitro method of screening panels of monoclonal antibodies for tumor bindingM Rusckowski, P W Doherty, F Virzi, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|June 1, 1996
Investigations of directly labeling antibodies with rhenium-188P Winnard, E Virzi, M Fogarasi, et al.
Nuclear Medicine and Biology|February 1, 1993
Improved tumor localization with (strept)avidin and labeled biotin as a substitute for antibodyD J Hnatowich, B Fritz, F Virzi, et al.
Pageof 6